Skip to main content
. 2022 May 12;12:7843. doi: 10.1038/s41598-022-11879-1

Figure 1.

Figure 1

Chemical structure of baricitinib and tofacitinib. The two drugs were the first JAK inhibitors to receive approval in the USA and Europe to treat rheumatoid arthritis.